Baystreet Staff - Wednesday, April 1, 2015 Coherus Biosciences (CHRS) down on new stock offering Coherus Biosciences, Inc. (NASDAQ: CHRS) slipped 9.1% to $27.81 after the company priced 4,137,931 shares of its common stock at $29.00 per share. Share volume was 561,000, compared to an all-day average of 46,000